Riskpilot← Back to searchSign inGet full accessMedikettu Oy
OYActiveY-tunnus 3087609-7Piispankatu 22Medical specialists activities · NACE 8622Est. 201927 employees
Revenue 2024
EUR 8M
+17% vs 2023
EBITDA margin
6.9%
+26% vs 2023
Equity ratio
45.6%
Financial strength
Net profit 2024
EUR 299K
+32% vs 2023
| Revenue | EUR 8M | +17% |
| EBITDA | EUR 550K | +26% |
| Net profit | EUR 299K | +32% |
| Total assets | EUR 1,8M | -5% |
| Equity | EUR 802K | +58% |
| Employees | 27 | — |
Legal name
Medikettu Oy
Y-tunnus number
3087609-7
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
18. syyskuuta 2019
Share capital
EUR 0
Employees
27 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Lääkäri ja lääkärikeskus, henkilövuokraus.
Address
Piispankatu 22
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 225 | 4 350 | 5 595 | 6 847 | 8 028 |
| Staff expenses | −189 | −717 | −893 | −1 196 | −1 512 |
| EBITDA | 11 | 214 | 373 | 436 | 550 |
| Depreciation & amort. | −74 | −71 | −68 | −103 | −142 |
| EBIT | −62 | 143 | 305 | 333 | 408 |
| Net financials | −4 | −56 | −29 | −48 | −33 |
| Profit before tax | −67 | 87 | 276 | 284 | 375 |
| Tax | −0 | 4 | 55 | 57 | 75 |
| Net profit | −67 | 83 | 221 | 228 | 299 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 522 | 824 | 1 519 | 1 863 | 1 761 |
| Equity | −67 | 16 | 536 | 509 | 802 |
| Long-term debt | 432 | 397 | 165 | 499 | 299 |
| Short-term debt | 157 | 410 | 818 | 855 | 659 |
| Total debt | 589 | 808 | 983 | 1 354 | 958 |
EBITDA margin
6.9%
This company
15.8%
Market median
-56% vs market
20202024
Equity ratio
45.6%
This company
38.2%
Market median
+19% vs market
20202024
Return on equity
37.3%
This company
18.4%
Market median
+103% vs market
20202024
Net profit margin
3.7%
This company
8.1%
Market median
-54% vs market
20202024
Asset turnover
4.56×
This company
1.12×
Market median
+307% vs market
20202024
Debt / equity
1.19×
This company
0.62×
Market median
-92% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2019-08-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
IA Chief Executive Officer | Chief Executive Officer | 2019 |
JR Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2024 | |
| Chairperson | 2019 | |
| Board of Directors | 2020 | |
| Former (1) | ||
| Board of Directors | 2020 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medikettu Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Iiro Aleksi Välimäki | Chief Executive Officer | 0 companies |
| Jere-Joonas Riivari | Deputy Chief Executive Officer | 0 companies |
| Minna Kristiina Palhamo | Board of Directors | 0 companies |
| Joonas Henri Tapani Tynkkynen | Chairperson | 0 companies |
| Antti Sakari Välimäki | Board of Directors | 0 companies |
| Carl Christian Lybäck | Board of Directors | 0 companies |